JP2001272392A - Method for measuring physiological function and testing food - Google Patents

Method for measuring physiological function and testing food

Info

Publication number
JP2001272392A
JP2001272392A JP2000082170A JP2000082170A JP2001272392A JP 2001272392 A JP2001272392 A JP 2001272392A JP 2000082170 A JP2000082170 A JP 2000082170A JP 2000082170 A JP2000082170 A JP 2000082170A JP 2001272392 A JP2001272392 A JP 2001272392A
Authority
JP
Japan
Prior art keywords
subject
test
measuring
test food
food
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000082170A
Other languages
Japanese (ja)
Other versions
JP3611996B2 (en
Inventor
Toshio Kobayashi
登史夫 小林
Bunsei Chin
文西 陳
Saburo Nakazawa
三郎 中澤
Kenji Fujiwara
研司 藤原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Science and Technology Agency
Original Assignee
Japan Science and Technology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science and Technology Corp filed Critical Japan Science and Technology Corp
Priority to JP2000082170A priority Critical patent/JP3611996B2/en
Publication of JP2001272392A publication Critical patent/JP2001272392A/en
Application granted granted Critical
Publication of JP3611996B2 publication Critical patent/JP3611996B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

PROBLEM TO BE SOLVED: To enable precise measurements on physiological functions for clearly evaluating and managing the features and problems to life-style related diseases by individuals. SOLUTION: Testing food material A is material A is dished out by a moderate weight according to the amounts of food ingested in the morning, noon and evening for the past several weeks of each subject as a tested subject, and testing food C for three days, that is, nine times in total is prepared. Raw grains of rice (30 grains/time) colored in nine colors and easily discriminated are mixed with the testing food C. Only this testing food C by each subject and designated drinks are taken in by the subjects, from whom urine D' and blood F' have been sampled immediately before the test start under the normal living conditions (three consecutive days), and immediately before and after the end of the third day's test, the subjects, urine D1, D2, excrement E1, E2, and blood F1, F2 are sampled. Various measurements are made on the samples of the of three kinds and eight specimens.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、生理機能の計測方
法及び試験用食品に係り、特に、個人別の生理機能(飲
食物を摂取した後排泄するまでの消化・吸収・代謝など
の消化管を中心とした生理的な活性や機能)を計測し
て、各人の生活習慣病に対する特性や問題点を明確に評
価・管理する生理機能の計測方法及び試験用食品に関す
る。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for measuring physiological functions and a food for testing, and more particularly to a physiological function for each individual (digestion, absorption, metabolism, etc., from ingestion to excretion after ingestion of food or drink). The present invention relates to a physiological function measuring method and a test food for measuring and evaluating the characteristics and problems of each person with respect to lifestyle-related diseases by measuring physiological activities and functions centered on the subject.

【0002】[0002]

【従来の技術】近年、人々の食生活は、豊かで多彩なも
のとなっている。しかし、この複雑化した社会では、人
々は、偏食、過食、拒食、運動不足等が習慣化した、い
わゆる「生活習慣病」と呼ばれる状況に陥りやすくなっ
ている。例えば、日本人の食生活の場合、1960年代
以降、約40年間、過剰摂取気味と言われている。特
に、肥満、糖尿病、高血圧症、高脂血症、動脈硬化症、
一部のガン(乳ガン、直腸ガンなど)等の生活習慣病患
者の数は、潜在的なものまで含めると1300万人を超
えるとまで言われている。さらに、日本での国民医療費
の増加率は、GNPのそれを上回っており、日常的な健
康評価及び管理の新たな展開が求められている。
2. Description of the Related Art In recent years, people's eating habits have become rich and varied. However, in this complicated society, people are more likely to fall into a so-called "lifestyle-related disease" in which eating habits such as unbalanced eating, overeating, anorexia, and lack of exercise have become habitual. For example, in the case of Japanese eating habits, overdose has been said to be overdose for about 40 years since the 1960s. In particular, obesity, diabetes, hypertension, hyperlipidemia, arteriosclerosis,
It is said that the number of patients with lifestyle-related diseases such as some cancers (breast cancer, rectal cancer, etc.) exceeds 13 million including potential ones. Furthermore, the rate of increase in national medical expenses in Japan exceeds that of GNP, and new development of daily health assessment and management is required.

【0003】“医食同源”と云われる通り、食生活や消
化・吸収・代謝機能などを個人別に精密に計測すること
は、快適な健康状態を維持・管理する上で非常に重要で
ある。特に、高齢者の、偏食や過食による健康の維持・
管理では、長年にわたる生活習慣の影響を受けることで
生じた、大きな個人差を、一般論や平均値ではなく、よ
り厳密に判定し、1人1人の治療や指導に役立てる方法
が切望されている。
[0003] As referred to as "medical and dietary sources", it is very important to precisely measure dietary habits, digestion, absorption, metabolic functions, and the like for each individual in maintaining and managing a comfortable health condition. . In particular, maintaining and maintaining the health of elderly people due to uneven eating and overeating
In management, there is a long-awaited need for a method to determine the great individual differences caused by the influence of lifestyles over many years, rather than using general theory and average values, to determine them more rigorously and to use them in individual treatment and guidance. I have.

【0004】[0004]

【発明が解決しようとする課題】近年、患者1人毎の遺
伝子を精密に解析したTaylor made 治療が注目されてい
るが、遺伝子の解析よって、生活習慣に起因する個人別
の生理活性や生理機能の識別を行うことは、遺伝子から
は直接的な関係が乏しく、困難と考えられる。具体的に
は、Taylor made 治療に関して、近年“DNAチップ
ス”などによる遺伝子解析が喧伝されているが、遺伝子
は個体の先天的な初期条件を決めているだけであって、
後天的な生活習慣病の実態に対しては間接的な役割は認
めるものの、個人別の生理活性や生理機能を把握・特定
することはできない。さらには、個人の生理活性や生理
機能は固定したものではなく、加齢・季節・生活環境・
諸ストレスなどにより容易に変化してしまう性格のため
に、生活習慣に起因する個人別の生理活性や生理機能の
識別は、1度だけの計測ではなく、例えば、一定の時間
間隔で恒常的又は定期的に行う必要がある。
In recent years, attention has been paid to Taylor made treatment in which the gene of each patient has been precisely analyzed. It is considered that it is difficult to discriminate between the genes because the direct relationship is poor from the gene. Specifically, regarding Taylor made treatment, gene analysis using "DNA chips" has been promoted in recent years, but genes only determine innate initial conditions of individuals,
Although there is an indirect role in the actual condition of acquired lifestyle-related diseases, it is not possible to grasp and identify the physiological activities and physiological functions of individuals. Furthermore, the physiological activities and physiological functions of individuals are not fixed, and aging, season, living environment,
Due to the personality that easily changes due to various stresses, the identification of individual physiological activities and physiological functions due to lifestyle is not a single measurement, but may be performed at regular time intervals or You need to do it regularly.

【0005】また、機能性食品などの研究開発によっ
て、食品成分(消化器へのインプット)の分子レベルま
での詳細な分析が可能となり、食品に含まれる各分子の
役割や機能、さらには、所望の役割や機能を果たす分子
を生成することができるようになりつつある。また、血
液・尿の成分に関しては既に多くの知見が集積している
が、摂取された食品と、また体調や疾病などと糞便との
精密な成分的な関係は、生理学的にも極く入り口が解明
されているのみであり、個人別の機能特性までも対象と
するならば膨大な未知の研究課題が残されている領域で
ある。
[0005] Research and development of functional foods and the like have enabled detailed analysis of food components (inputs to the digestive organs) down to the molecular level. It is becoming possible to generate molecules that fulfill the role and function of. In addition, although a great deal of knowledge has already been accumulated regarding the components of blood and urine, the precise compositional relationship between ingested foods and stool with physical conditions and diseases is extremely important physiologically. This is an area in which a huge amount of unknown research issues remain if the target is to cover functional characteristics of individuals.

【0006】さらに、血液はもとより尿・大便など(消
化器からのアウトプット)の成分組成など多様な生化学
成分を対象にしたバイオセンサーの開発、近赤外分光法
等による簡易な定量計測技術の発達、また、コンピュー
ターのハードディスクなど記憶媒体の大容量化に伴う膨
大なデータの簡易な解析・処理等の急速な発達により、
人体の諸生理活性に関する膨大な情報資源から、有意な
個人情報を抽出できる段階に現在は直面している。
Further, development of biosensors for various biochemical components such as components of blood, urine, stool, etc. (output from digestive organs), and simple quantitative measurement technology by near infrared spectroscopy, etc. And the rapid development of simple analysis and processing of enormous data due to the increase in capacity of storage media such as computer hard disks,
Currently, we are facing the stage where significant personal information can be extracted from a vast amount of information resources on various physiological activities of the human body.

【0007】本発明は、以上の点に鑑み、個人別の生理
機能を計測して、各人の生活習慣病等に対する特性や問
題点を明確に評価及び管理する、生理機能の計測方法及
び試験用食品を提供することを目的とする。
[0007] In view of the above, the present invention measures a physiological function for each individual and clearly evaluates and manages the characteristics and problems of each person with respect to lifestyle-related diseases and the like, and a method and test for measuring physiological functions. The purpose is to provide food for use.

【0008】[0008]

【課題を解決するための手段】本発明の第1の解決手段
によると、特定の疾患に対応させて指標となる成分を添
加した試験用食品素材を生成し、前記試験用食品素材
を、予め特定の生理機能を測定するための試料を採取さ
れた被験者に対して、日常の食事摂取量に基づいた量に
取り分け、試験用食品を生成し、生成された試験用食品
を、前記被験者に対して所定の期間及び回数摂取させた
後、前記被験者から、特定の生理機能を測定するための
試料を採取し、採取された試料に基づいて、前記被験者
の特定の消化器系又は循環器系疾患に対する状態を求め
るようにした生理機能の計測方法を提供する。
According to a first aspect of the present invention, a test food material to which a component serving as an index is added corresponding to a specific disease is generated, and the test food material is prepared in advance. For a subject from which a sample for measuring a specific physiological function was collected, set aside a quantity based on daily food intake, generate a test food, and generate the generated test food for the subject. After taking a predetermined period and number of times, a sample for measuring a specific physiological function is collected from the test subject, and based on the collected sample, a specific digestive system or circulatory system disease of the test subject. The present invention provides a physiological function measurement method for determining a state of a physiological function.

【0009】本発明の第2の解決手段によると、被験者
に摂取され、被験者の特定の疾患を計測するための試験
用食品であって、ビタミン、ミネラル類を主体とするベ
ーサル・ダイエットと、食物繊維と、アルブミンと、キ
シロースと、調香味成分と水を含み、予め特定の生理機
能を測定するための試料を採取された被験者に対して、
日常の食事摂取量に基づいた量に取り分けられたことを
特徴とする試験用食品を提供する。
According to a second solution of the present invention, there is provided a test food to be taken by a subject for measuring a specific disease of the subject, comprising: a basal diet mainly composed of vitamins and minerals; Fiber, albumin, xylose, containing a flavor component and water, for a subject from which a sample for measuring a specific physiological function was previously collected,
To provide a test food characterized by being divided into quantities based on daily dietary intake.

【0010】[0010]

【発明の実施の形態】1.概要 本発明は、一連の“計測(検査)・評価・判定システ
ム”の基本コンセプトを対象にしている。まず、本発明
に関する検査システムの概要を説明する。検査システム
は、被験者の検査用食品を選定すると共に、被験者の摂
食・生活実態を把握し、被験者の血液・尿・糞便等を採
取・分析する。さらに、その分析結果に基づいて、個人
別生理機能の評価・診断・治療指針の決定を行う(な
お、この検査・判定は、被験者個人で日常的に行うこと
もできる。)。
BEST MODE FOR CARRYING OUT THE INVENTION Overview The present invention is directed to the basic concept of a series of “measurement (inspection), evaluation, and judgment systems”. First, an outline of an inspection system according to the present invention will be described. The test system selects test subjects' test foods, grasps the subjects' eating and living conditions, and collects and analyzes the subjects' blood, urine, feces, and the like. Further, based on the analysis result, evaluation, diagnosis, and treatment guidelines for individual physiological functions are determined (this test / determination can also be performed on a daily basis by a subject).

【0011】被験者は、一定期間(例えば、3〜10日
間ほど)、一般の食品ではなく“化学成分的に調整され
た食品(検査の対象となる疾病によって異なる)”を、
摂取しながら通常の生活下で“総合的な検査”を受ける
(但し、被験者が重症の場合、入院した状態でこの検査
を受けることもできる)。なお、被験者は、量を測りさ
えすれば、自由に水を摂取できる。また、数日間にわた
って摂取する加工・調整済み食品(化学成分的に調整さ
れた食品)の受容性(食べ易さ)は、近年の製造技術の
進歩により大幅に改善されている。
For a certain period of time (for example, about 3 to 10 days), the subject is asked to give “chemically adjusted food (depending on the disease to be tested)” instead of general food.
Take a “comprehensive test” under normal living conditions while ingesting (however, if the subject is severely ill, this test can be taken while in the hospital). The subject can freely take water as long as the amount is measured. In addition, the acceptability (ease of eating) of processed and adjusted foods (foods adjusted in terms of chemical components) to be ingested over several days has been greatly improved by recent advances in manufacturing technology.

【0012】次に、検査の直前、検査中、検査後の数箇
所の時点で採取された被験者からの試料(血液、尿、糞
便、など)と現在の病状とを、数値的な面から“精密解
析”することにより、被験者の消化・吸収・代謝などに
関する生理活性や生理機能を判定・評価する。例えば、
唾液などの生化学的な成分の他に、検査期間中の日常行
動(睡眠・起床時間、飲食・排尿便の回数と量、運動量
等)と生理状態を表す指標類(体温、血圧、心拍数、呼
吸量、心電図等)を連続計測する。尿の主な検査項目
は、pH、比重、蛋白、ブドウ糖、ケトン体、潜血反
応、ビリルビン、ウロビリノーゲン、亜硝酸塩、白血球
反応、アスコルビン酸、細菌類(腸内細菌類、緑膿菌、
ブドウ球菌等)等である。糞便の主な検査項目は、潜血
反応、脂肪、ビリルビン/ウロビリン体、酵素類(トリ
プシン/キモトリプシン等)、細菌類(下痢性大腸菌
類、嫌気性菌類、病原性菌(ビブリオ、サルモネラ、エ
ルシニア等))等である。
Next, samples (blood, urine, stool, etc.) from the subject collected at several points immediately before, during, and after the test and the current medical condition are numerically described as " By performing "precision analysis", the physiological activities and physiological functions related to digestion, absorption, metabolism, etc. of the subject are determined and evaluated. For example,
In addition to biochemical components such as saliva, daily activities (sleep and wake-up time, number and volume of eating and drinking and urinary defecation, exercise amount, etc.) and indicators (physical temperature, blood pressure, heart rate) , Respiratory volume, electrocardiogram, etc.). The main test items of urine are pH, specific gravity, protein, glucose, ketone body, occult blood reaction, bilirubin, urobilinogen, nitrite, leukocyte reaction, ascorbic acid, bacteria (intestinal bacteria, Pseudomonas aeruginosa,
Staphylococci and the like). The main test items for feces are occult blood reaction, fat, bilirubin / urobillin, enzymes (trypsin / chymotrypsin, etc.), bacteria (diarrheal Escherichia coli, anaerobic bacteria, pathogenic bacteria (vibrio, salmonella, yersinia, etc.)) ).

【0013】さらに、本発明は、前述の検査によって得
られた結果と、食生活を中心とする被験者に関する諸調
査とから、各個人別の生活習慣内容の得失や改善点・問
題点を整理・評価して治療や生活指導に応用することが
できる。なお、この諸調査としては、尿・糞便中に含ま
れる化学成分の定量計測が主であり、上述したバイオセ
ンサー技術、DNAセンター技術又は非破壊的な近赤外
分光法の応用による統計的な迅速定量計測方法等によっ
て、より精密かつ迅速な計測を実施することができる。
また、各個人別の生活習慣内容としては、被験者の既往
症や親兄弟等の病歴、居住地・生活記録、食べ物の好き
嫌い、喫煙習慣の程度、日常的な摂食内容、など生活習
慣病の原因と目される諸因子類がある。
[0013] Furthermore, the present invention organizes the advantages and disadvantages of each individual's lifestyle habits, as well as points of improvement and problems, based on the results obtained by the above-described tests and various surveys on subjects mainly on eating habits. It can be evaluated and applied to treatment and lifestyle guidance. In addition, as for these various investigations, quantitative measurement of chemical components contained in urine and feces is mainly performed, and statistical analysis using the above-described biosensor technology, DNA center technology, or nondestructive near-infrared spectroscopy is performed. More accurate and quick measurement can be performed by a rapid quantitative measurement method or the like.
The lifestyle habits for each individual include the causes of lifestyle-related diseases, such as the subject's past illness, the medical history of parents and siblings, the place of residence and life, the likes and dislikes of food, the degree of smoking habits, and the content of daily eating. There are various factors that are considered to be.

【0014】さらに、個人の生理機能は一定状態に固定
したものではないため、生活環境からの諸ストレス、睡
眠、飲食・喫煙などの状況等により、個人の生理的諸活
性は、短期間にも大幅に変動する可能性があるため、治
療の対象となる総合的かつ精密な個人別生理機能の計測
評価だけでなく、一般の市民が自宅で日常的に自己管理
が行える簡便な計測・評価システムも必要とされる。例
えば、“総合的な検査”は、疾病の内容や症状にも拠る
が、「1回/6〜15ヶ月程」の実施頻度が必要である
場合が多い。これに対して、本発明のような一般の市民
が自宅で日常的に自己管理が行える簡便な計測・評価シ
ステムでは、上述の検査結果により特定された疾病・症
状の“個人別の日常管理”を主な目標にしており、簡便
で、「1回/2〜4週間程」の実施頻度で検査ができ、
さらに、患者等の自宅で確実に実行できる。具体的に
は、実施に数日間も掛かるような総合的な検査ではな
く、極く軽度の疾病兆候を示している被験者の日常生活
管理を目的とするために、1食ほどの応用で一応の結論
が出せるように“特定項目”を対象にした簡便な検査を
提供することができる。
Furthermore, since the physiological function of an individual is not fixed, the physiological activities of the individual may be reduced in a short time due to various stresses from the living environment, sleep, eating, drinking and smoking. Because of the possibility of drastic fluctuations, not only comprehensive and precise measurement and evaluation of individual physiological functions to be treated, but also a simple measurement and evaluation system that allows ordinary citizens to manage themselves at home on a daily basis. Is also required. For example, the “comprehensive test” often depends on the content and symptoms of the disease, but often needs to be performed “once every 6 to 15 months”. On the other hand, in a simple measurement / evaluation system in which ordinary citizens can self-manage at home on a daily basis as in the present invention, the “individual daily management” of the disease / symptom specified by the above-described test results is performed. The main goal is to be able to conduct tests easily and with a frequency of "once / about 2 to 4 weeks"
Furthermore, it can be reliably executed at home such as a patient. Specifically, it is not a comprehensive test that takes several days to perform, but it is intended to manage the daily life of subjects who show very mild signs of illness. It is possible to provide a simple test for “specific items” so that a conclusion can be made.

【0015】また、本発明では、化学成分的に調整・配
合された食品を摂取し、尿・糞便などを自己検査するこ
とにより、自己の健康状態を的確に把握する。具体的に
は、摂取する食品に指標となる成分を添加し、その消化
管内における消長・代謝などによって、尿・糞便などに
現れる兆候(最も簡便には色素などにより判定)を識別
・評価する。
Further, in the present invention, a self-health condition is accurately grasped by ingesting a food prepared and formulated as a chemical component and performing a self-test on urine and feces. Specifically, a component serving as an index is added to the food to be ingested, and signs (appearance most easily determined by a pigment or the like) appearing in urine, feces, etc. are identified and evaluated based on their fate and metabolism in the digestive tract.

【0016】さらに、本発明における化学成分的に調整
・配合された食品は、標準的な疾病内容に合わせた“普
遍的検査用食品(主成分、副成分、指標成分など何段階
かに分けた上で、対象による組み合わせを行う)”の他
に、個人別の対象となる疾病状況に合わせた“注文型検
査用食品”を製造・供給する。具体的には、治療の対象
となる疾患別に被験者の持つ生理機能を幾つかに分類す
ることにより、それぞれの指標成分の消化管内における
消長が日常的に検査できる(さながら“既製服の型番”
のように、自分のサイズとその変動を理解することがで
きる)。
Further, the food prepared and formulated as a chemical component in the present invention is divided into several types of “universal test foods (main components, subcomponents, indicator components, etc.) in accordance with the standard disease content. In addition to the above-mentioned “combination by subject”), “tailor-made test foods” are manufactured and supplied according to the disease condition targeted by each individual. Specifically, by classifying the physiological function of the subject into several types according to the disease to be treated, the change of each index component in the digestive tract can be inspected on a daily basis (just like the “model of ready-made clothes”
Like, you can understand your size and its fluctuations).

【0017】2.被験者が摂取する食品の構成 (1)被験者が摂取する食品は、化学的及び/或いは生
化学的及び/或いは微生物学的に処理された特定成分と
ビタミン類、ミネラル類を含有する食品であり、摂取
前、摂取中、摂取後に被験者の血液、尿、糞便、唾液等
の物理的生理活性を収集、検査及び評価を行う。 (2)被験者が摂取する食品は、化学的及び/或いは生
化学的及び/或いは微生物学的に処理された炭水化物を
主体とする食品である。 (3)被験者が摂取する食品は、化学的及び/或いは生
化学的及び/或いは微生物学的に処理された蛋白質を主
体とする食品である。 (4)被験者が摂取する食品は、化学的及び/或いは生
化学的及び/或いは微生物学的に処理された脂質を主体
とする食品である。
2. Composition of Foods Taken by Subject (1) Foods taken by the subject are foods containing specific components, vitamins, and minerals that have been chemically and / or biochemically and / or microbiologically treated. Before, during, and after ingestion, the physical physiological activities of the subject such as blood, urine, feces, and saliva are collected, examined, and evaluated. (2) The food consumed by the subject is a food mainly composed of carbohydrates that have been chemically and / or biochemically and / or microbiologically treated. (3) Foods to be ingested by the subject are foods mainly composed of chemically and / or biochemically and / or microbiologically processed proteins. (4) The food that the subject ingests is a food containing mainly lipids that have been chemically and / or biochemically and / or microbiologically treated.

【0018】3.具体的な検査方法 3−1.第1の検査方法 第1の検査方法は、一例として、3日間(食事が9回
分)にわたる所定の集団による生理機能の検査方法を示
す。まず、重量換算で、ビタミン、ミネラル類を主体と
するベーサル・ダイエット0.3%、分子量10万−1
5万に分割されたマンナン(食物繊維)8.7%、分子
量3万−5.5万に分割されたアルブミン2.2%、キ
シロース1.8%、調香味成分0.05%、残りは水で
満たして100.0%にした試験用食品素材(A)を作
る。
3. Specific inspection method 3-1. First Test Method The first test method is, for example, a test method of a physiological function by a predetermined group for three days (9 meals). First, on a weight basis, 0.3% of a basal diet mainly composed of vitamins and minerals, and a molecular weight of 100,000-1
8.7% of mannan (dietary fiber) divided into 50,000, 2.2% of albumin divided into molecular weight of 30,000 to 55,000, 1.8% of xylose, 0.05% of flavoring component, and the rest A test food material (A) filled to 100.0% with water is prepared.

【0019】この試験用食品素材(A)を検査の対象と
なる被験者1人1人の過去数週間の朝昼晩の摂食量に基
づいて、適度な重量に取り分けると共に、3日分・計9
回の試験用食品(C)を作る。さらに、この試験用食品
(C)に対して、9色に着色され、分別が容易な生の米
粒(30粒/回)を、混入する。この各被験者別の試験
用食品(C)と所定の飲料のみを、検査開始直前、尿
(D’)、血液(F’)を採取された被験者に対して、
通常の生活(連続した3日間)の下で摂取させると共
に、第3日目の試験終了直前と直後、被験者の尿(D
1、D2)、糞便(E1、E2)、血液(F1、F2)
を採取した。
The test food material (A) is divided into appropriate weights based on the amount of food consumed by each subject to be examined during the past few weeks in the morning, noon, and evening, and three days for a total of 9 meals.
Make test food (C) twice. Further, the test food (C) is mixed with raw rice grains (30 grains / time) which are colored in nine colors and are easily separated. Only the test food (C) and the predetermined beverage for each subject were subjected to urine (D ') and blood (F') immediately before the start of the test.
Ingestion was performed under normal life (for three consecutive days), and immediately before and immediately after the end of the test on the third day, urine (D
1, D2), feces (E1, E2), blood (F1, F2)
Was collected.

【0020】この採取された3種類・8検体の試料に対
して、それらの重量だけでなく、尿(D’→D1、D
2)については、pH、タンパク、ブドウ糖、ケトン
体、ビリルビン、ウロビリン体、尿素窒素、電解質の濃
度を測定した。また、糞便(E1、E2)については、
排出されている着色米粒の色分けと数、脂肪、潜血反
応、ビリルビン、ウロビリン体の濃度と、水で約4倍に
希釈した便溶液のpHを排便直後と、それを平均23℃
に保存して6時間おきに丸1.5日後までの7回の変化
を測定しその間のpH値を測定した。
With respect to the collected three kinds and eight samples, not only their weights but also urine (D ′ → D1, D
Regarding 2), the concentrations of pH, protein, glucose, ketone body, bilirubin, urobilin body, urea nitrogen, and electrolyte were measured. For feces (E1, E2),
Immediately after defecation, the coloration and number of the colored rice grains discharged, the concentration of fat, occult blood reaction, bilirubin, urobilin body, and the pH of the stool solution diluted about 4 times with water, and the average of 23 ° C
The pH was measured every 7 hours until the end of 1.5 days.

【0021】血液(F’→F1、F2)については、脂
質検査(T−cho:総コレステロール値、TG:中性
脂肪量、HDL−cho:HDLコレステロール値)、
肝機能検査(ZTT:硫酸亜鉛混濁試験(zinc sulfate
turbidity test)、GOT(glutamic-oxalacetate tran
saminase)、GPT(glutamic-pyruvate transaminase)、
γ−GTP(γ-glutamyl transpeptidase))、腎機能検
査(尿酸、クレアチニン)、血液一般検査(血糖、血清
アミラーゼ、白血球数、赤血球数、メモグロビン量、ヘ
マトクリック値)の濃度を測定した。
For blood (F ′ → F1, F2), lipid test (T-cho: total cholesterol level, TG: triglyceride level, HDL-cho: HDL cholesterol level),
Liver function test (ZTT: zinc sulfate opacity test (zinc sulfate
turbidity test), GOT (glutamic-oxalacetate tran
saminase), GPT (glutamic-pyruvate transaminase),
The concentrations of γ-GTP (γ-glutamyl transpeptidase), renal function tests (uric acid, creatinine), and general blood tests (blood sugar, serum amylase, white blood cell count, red blood cell count, memoglobin amount, hematocrick value) were measured.

【0022】これら測定結果の数値を総合して重回帰分
析を行うことにより、既に糖尿病と高血圧症の治療を受
けている被験者はもとより、まだ具体的な症状を示して
いない被験者の集団を、「直ちに生活習慣上の対応が必
要なグループ(赤信号)」、「折に触れて健康状態を検
査するグループ(黄信号)」、「当面は心配の不要なグ
ループ(青信号)」、の3種類に分別することができ
る。
By performing a multiple regression analysis by integrating the numerical values of these measurement results, a group of subjects who have not already been treated for diabetes and hypertension, as well as subjects who have not yet exhibited specific symptoms, can be classified into “ There are three groups: a group that needs immediate attention in terms of lifestyle (red light), a group that occasionally checks their health (yellow light), and a group that does not need to worry for the time being (green light). Can be separated.

【0023】3−2.第2の検査方法 第2の検査方法は、例えば、3〜4回の食事程度で検査
が終了し、素人の“自己検査”を達成するものである。
まず、重量換算で、ビタミン、ミネラル類を主体とする
ベーサル・ダイエット0.3%、分子量10万−15万
に分割されたマンナン8.7%、分子量3万−5.5万
に分割されたアルブミン2.2%、キシロース1.8
%、調香味成分0.05%、残りは水で満たして10
0.0%にした試験用食品(P)を作る。
3-2. Second inspection method In the second inspection method, for example, the inspection is completed after about three to four meals, thereby achieving the “self-inspection” of the amateur.
First, by weight conversion, it was divided into 0.3% of basal diet mainly composed of vitamins and minerals, 8.7% of mannan divided into 100,000 to 150,000 molecular weight, and 30,000 to 55,000 molecular weight. Albumin 2.2%, xylose 1.8
%, Flavoring ingredient 0.05%, the rest is filled with water 10
A test food (P) having a concentration of 0.0% is prepared.

【0024】この試験用食品(P)を、上述の第1の検
査方法の結果、「黄信号」と「青信号」に分類された被
験者に対して、晩朝昼晩の4回の食事に試験用食品
(P)と飲料のみを摂取させる。摂取終了の翌朝、被験
者から尿(Q)と糞便(R)を採取する。尿(Q)につ
いては、尿試験紙によりタンパクと糖の濃度を測定し
た。また、糞便(R)については、便潜血テスト試薬に
より潜血反応を、水で約4倍に希釈した便溶液のpHを
排便直後と、1日後の2回をpH試験紙で測定する。
The test food (P) was tested on subjects classified as "yellow light" and "green light" as a result of the first inspection method described above, with four meals of late morning, noon and evening. Food (P) and beverages only. On the morning following the end of the intake, urine (Q) and feces (R) are collected from the subject. For urine (Q), protein and sugar concentrations were measured using urine test paper. For feces (R), the occult blood reaction is measured by a fecal occult blood test reagent, and the pH of a stool solution diluted about 4 times with water is measured immediately after defecation and twice a day after using a pH test paper.

【0025】その間のpHの変化から、被験者は、被験
者個人の消化管系の生理機能の状態を直接的に自己判定
し、各自が医師らと至急接触する必要があるか否かを自
分で判断できる。
From the change in pH during this period, the subject directly makes a self-judgment of the state of the physiological function of the digestive tract system of the individual, and judges whether or not each of them needs to make immediate contact with doctors. it can.

【0026】3−3.第3の検査方法 まず、重量換算で、ビタミン、ミネラル類を主体とする
ベーサル・ダイエット0.3%、分子量10万−15万
に分割されたマンナン8.7%、分子量3万−5.5万
に分割されたアルブミン2.2%、キシロース1.8
%、純度95%以上のリノレン酸1.2%(I)/5.
2%(II)/9.6%(III)、調香味成分0.05
%、残りは水で満たして100.0%にした試験用食品
素材(A−I、A−II、A−III)の3種類を作る。
3-3. Third Inspection Method First, in terms of weight, 0.3% of basal diet mainly composed of vitamins and minerals, 8.7% of mannan divided into 100,000 to 150,000 molecular weight, and 30,000 to 5.5 molecular weight Albumin 2.2%, xylose 1.8 divided into 10,000
%, Linolenic acid with a purity of 95% or more 1.2% (I) / 5.
2% (II) /9.6% (III), flavor component 0.05
%, The remainder being filled with water to make 100.0%, to produce three types of test food materials (AI, A-II, A-III).

【0027】この試験用食品素材(A−I、A−II、A
−III)を、検査の対象となる被験者(軽度の高脂血症
患者3名、健常者3名、計6名)の過去1週間の朝昼晩
の摂食量に基づいて、適度な重量に取り分けると共に、
3日分・計9回の試験用食品を作る(C−I、C−II、
C−III)。さらに、試験用食品(C−I、C−II、C−
III)を、各被験者6名に対して、連続した3日間、1
日目は、(C−I)を与え、間を1週間ほど空けて、2
日目は(C−II)、さらに、1週間ほど空けて、3日目
は(C−III)というように、3回摂食させて、それぞ
れの摂食直前、1日目、2日目、3日目計4回、血液、
尿、糞便を採取し、それらの成分を詳細に検討した。こ
の検討結果によると、血液中の脂質成分について、最も
明確な変化が現れた。最も脂質(リノレン酸)含量の少
ない試験用食品(C−I)と多い試験用食品(C−III)
では、3日後に約3倍の血液中の脂質成分の変化が認め
られた。また、尿と糞便中の成分の細かな偏差は、極め
て複雑であり、いずれも単独で突出する現象は認められ
なかったが、消化管ホルモンである血中ガストリンや膵
ホルモンのグルカゴンの動態には、明確な偏差が表れて
いた。
This test food material (AI, A-II, A
-III) was adjusted to an appropriate weight based on the amount of food consumed by the test subjects (three patients with mild hyperlipidemia and three healthy subjects, a total of six) in the morning, lunch, and night in the past week. Together with
Make test food for 3 days, 9 times in total (C-I, C-II,
C-III). Furthermore, test foods (C-I, C-II, C-
III) was administered to 6 subjects each for 3 consecutive days.
On the day, (C-I) is given, with a week
On the day, (C-II), and further about one week apart, on the third day, (C-III), they were fed three times, just before each meal, the first day, the second day On the third day, four times, blood,
Urine and feces were collected and their components were examined in detail. According to the results of this study, the most obvious changes appeared in lipid components in blood. Test food with the lowest lipid (linolenic acid) content (C-I) and test food with the highest content (C-III)
3 days later, about three times the change in the lipid component in the blood was observed. The minute deviations between the components in urine and feces were extremely complicated, and none of them protruded independently.However, the dynamics of blood gastrin, a gastrointestinal hormone, and glucagon, a pancreatic hormone, were not observed. , A clear deviation appeared.

【0028】3−4.第4の検査方法 まず、重量換算で、ビタミン、ミネラル類を主体とする
ベーサル・ダイエット0.3%、分子量10万−15万
に分割されたマンナン8.7%、分子量3万−5.5万
に分割されたアルブミン2.2%、キシロース1.8
%、純度95%以上のリノレン酸1.2%、調香味成分
0.05%、残りは水で満たして100.0%にした試
験用食品素材(A−I)を作る。
3-4. Fourth inspection method First, in terms of weight, 0.3% of basal diet mainly composed of vitamins and minerals, 8.7% of mannan divided into 100,000 to 150,000 molecular weight, and 30,000 to 5.5 molecular weight Albumin 2.2%, xylose 1.8 divided into 10,000
%, Linolenic acid having a purity of 95% or more, 1.2% of flavoring components, and the rest being filled with water to make a test food material (A-I) of 100.0%.

【0029】この試験用食品素材(A−I)を検査の対
象となる被験者(軽度の糖尿病患者3名、健常者3名、
計6名)の過去1週間の朝昼晩の摂食量に基づいて、適
度な重量に取り分けると共に、3日分・計9回の試験用
食品(C−I)を作る。さらに、試験用食品(C−I)の
摂食試験を行う際、9色(L〜T)に着色され、分別が
容易な生の大豆(3粒/回)を、L色の生大豆3粒(各
回の摂食10分前)、M色の生大豆3粒(摂食中間
点)、N色の生大豆3粒(摂食15分後)、という順で
被験者に丸呑みさせた。1日で9色の生大豆を使用する
ため、例えば、朝にL,M,N色、昼にO,P,Q色、
晩にR,S,T色の各生大豆を摂食する。さらに、2日
目以降も被験者に対して、1日目と同様に、再び9色
(L〜T)の生大豆を摂取させ、、3日目も同様の試験
を繰り返す。その結果、排出される糞便中に含まれる大
豆が体外に出てくる順番を調べ、、その順番に基づい
て、被験者の腸管内における物理的な混合状態を検査し
た。
The test food material (A-I) was tested for subjects (three mild diabetic patients, three healthy subjects,
Based on the amount of food consumed in the morning, noon, and evening for the past week (6 persons in total), the food is divided into appropriate weights, and the test food (C-I) is prepared 9 times in total for 3 days. Further, when conducting an eating test of the test food (C-I), raw soybeans (3 grains / time), which are colored in 9 colors (LT) and easy to separate, are mixed with L-colored raw soybeans. The subjects swallowed the grains in the order of the grains (10 minutes before each meal), three M-colored raw soybeans (midpoint of feeding), and three N-colored raw soybeans (15 minutes after eating). In order to use 9 colors of raw soybeans in one day, for example, L, M, N colors in the morning, O, P, Q colors in the daytime,
In the evening, eat raw R, S and T colored soybeans. Further, on the second and subsequent days, the subjects are again ingested 9 colors (LT) of raw soybeans as in the first day, and the same test is repeated on the third day. As a result, the order in which the soybeans contained in the excreted feces came out of the body was examined, and based on the order, the physical mixing state in the intestinal tract of the subject was examined.

【0030】また、摂食試験終了直後の平常食に戻った
際にも、2日間同様にL色〜T色までの生大豆丸呑み試
験を追加して、摂食内容の違いによる消化管内の混合状
態を調べた。その結果、糖尿病患者と健常者では、腸管
内の内容物の混合状態に顕著な差が認められた。、すな
わち、糖尿病患者には、いわゆる“ピストン流型”(管
の中を流体が流れるときに、ピストンのシリンダーが動
くのと同様に、管軸に直角な流速分布を持って、流れて
いる流体が整然と出口に向かって流れる現象)と呼ばれ
る現象が認められ、一方、健常者には、いわゆる“逆混
合”(管の中を流体が流れるときに、流れている流体の
一部が全体(見かけ)の流れに逆行して上流部に戻る現
象)と呼ばれる現象が認められた。なお、色付き生大豆
の摂食と排出過程を数値解析することにより、腸管内に
おける混合を伴う流動状態を、定量的に表現することも
できる。
Also, when returning to a normal diet immediately after the end of the feeding test, a raw soybean swallow test for L to T colors was added in the same manner for 2 days, and mixing in the digestive tract due to the difference in the content of the feeding. I checked the condition. As a result, between the diabetic patient and the healthy subject, a remarkable difference was observed in the mixed state of the contents in the intestinal tract. In other words, diabetic patients are referred to as the so-called "piston flow type" (flowing fluid having a flow velocity distribution perpendicular to the pipe axis, similar to the movement of a piston cylinder when fluid flows through the pipe). A phenomenon called so-called “back-mixing” (when fluid flows through a tube, a part of the flowing fluid appears as a whole) A phenomenon referred to as "returning to the upstream part in reverse to the flow of") was observed. In addition, by numerically analyzing the eating and discharging processes of colored raw soybeans, the flow state involving mixing in the intestinal tract can be quantitatively expressed.

【0031】なお、上述の検査方法において使用された
試験用食品素材の成分の種類及び量は、測定ができる範
囲であれば、適宜適宜変更できる。また、試験用食品素
材は、例えば、水溶性、非水溶性又は両方の食物繊維を
加えたり、対象となる疾患によっては、他の適宜の成分
を加えたり、不要となる成分を取り除く等、適宜変更で
きる。さらに、米粒、生大豆については、消化・分解さ
れず、着色等のマークが可能であれば、適宜別の食材を
利用できる。一方、着色数については、精密な測定が可
能であれば、9色に限られない。また、摂食タイミング
については、精密な測定が可能であれば、適宜のタイミ
ング及び回数でとることができる。
The types and amounts of the components of the test food material used in the above-described inspection method can be appropriately changed as long as they can be measured. In addition, the test food material, for example, water-soluble, water-insoluble or both dietary fiber, or depending on the disease of interest, other appropriate components, or remove unnecessary components, etc. Can be changed. Further, if the rice grains and raw soybeans are not digested and decomposed and can be marked with coloring or the like, other food materials can be used as appropriate. On the other hand, the number of colors is not limited to nine colors as long as accurate measurement is possible. In addition, the feeding timing can be set at an appropriate timing and number of times as long as accurate measurement is possible.

【0032】[0032]

【発明の効果】本発明によれば、各人の生活習慣病に対
する特性や問題点を明確に評価・管理する、消化及び生
理機能の精密な計測を行うことができる。
According to the present invention, it is possible to accurately measure digestive and physiological functions for clearly evaluating and managing the characteristics and problems of each person with respect to lifestyle-related diseases.

───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 2G045 AA15 AA22 AA25 BB24 CB03 CB04 CB20 CB30 DA36 FA11 4B018 LB04 LB10 LE02 MD49 MD58 ME11 MF14  ──────────────────────────────────────────────────続 き Continued on the front page F term (reference) 2G045 AA15 AA22 AA25 BB24 CB03 CB04 CB20 CB30 DA36 FA11 4B018 LB04 LB10 LE02 MD49 MD58 ME11 MF14

Claims (9)

【特許請求の範囲】[Claims] 【請求項1】特定の疾患に対応させて指標となる成分を
添加した試験用食品素材を生成し、 前記試験用食品素材を、予め特定の生理機能を測定する
ための試料を採取された被験者に対して、日常の食事摂
取量に基づいた量に取り分け、試験用食品を生成し、 生成された試験用食品を、前記被験者に対して所定の期
間及び回数摂取させた後、前記被験者から、特定の生理
機能を測定するための試料を採取し、 採取された試料に基づいて、前記被験者の特定の消化器
系又は循環器系疾患に対する状態を求めるようにした生
理機能の計測方法。
1. A subject who produces a test food material to which a component serving as an index is added in accordance with a specific disease, and from which a sample for previously measuring a specific physiological function is collected from the test food material. In contrast, the amount is divided into the amount based on the daily dietary intake, a test food is generated, and the generated test food is ingested to the subject for a predetermined period and a number of times. A method for measuring physiological functions, wherein a sample for measuring a specific physiological function is collected, and a state of the subject for a specific digestive system or circulatory system disease is determined based on the collected sample.
【請求項2】前記被験者が摂取する試験用食品は、炭水
化物、タンパク質、脂質のいずれかひとつを主体とする
食品であることを特徴とする請求項1に記載の生理機能
の計測方法。
2. The method for measuring physiological functions according to claim 1, wherein the test food taken by the subject is a food mainly containing one of carbohydrates, proteins, and lipids.
【請求項3】前記試験用食品として、生の米粒又は大豆
等の粒状食品をさらに摂取されるようにしたことを特徴
とする請求項1又は2に記載の生理機能の計測方法。
3. The method for measuring physiological functions according to claim 1, wherein granular foods such as raw rice grains or soybeans are further ingested as the test foods.
【請求項4】前記特定の生理機能を測定するための試料
は、被験者の尿、糞便であって、 前記尿のタンパクと糖など特定成分の濃度を測定すると
共に、前記糞便の潜血反応など特定成分を測定し、 前記被験者は、前記尿及び糞便の測定結果に基づいて、
自身の消化管系の生理機能の状態を自己判定するように
した請求項1乃至3のいずれかに記載の生理機能の計測
方法。
4. The sample for measuring the specific physiological function is urine or stool of a subject, and measures the concentration of a specific component such as protein and sugar in the urine, and specifies the occult blood reaction of the stool. Measuring the components, the subject, based on the measurement results of the urine and feces,
The physiological function measuring method according to any one of claims 1 to 3, wherein the state of the physiological function of the digestive tract system is determined by itself.
【請求項5】前記試験用食品素材を生成する場合、リノ
レン酸等の脂質を含む材料の分量に応じて、ひとつ又は
複数種類の試験用食品素材を生成し、 前記被験者に対して、所定の期間を空けた連続する日数
の間、複数種類の前記試験用食品素材を摂取させるよう
にした請求項1乃至3のいずれかに記載の生理機能の計
測方法。
5. When the test food material is produced, one or more test food materials are produced according to the amount of a material containing lipid such as linolenic acid, and The method for measuring physiological functions according to any one of claims 1 to 3, wherein a plurality of kinds of the test food materials are ingested for a continuous number of days separated by a period.
【請求項6】前記被験者に対して、それぞれ異なる色に
着色された複数の生大豆又は米粒等の粒状食品を、所定
の期間を空けて摂取させ、 前記被験者の特定の疾患に対する状態を求める場合、前
記被験者から排出された生大豆又は米粒の順番又は数に
基づいて、前記被験者の腸管内における混合状態を検査
するようにした請求項1乃至3のいずれかに記載の生理
機能の計測方法。
6. A method in which the subject is caused to ingest a plurality of granular foods such as raw soybeans or rice grains colored in different colors at predetermined intervals, and the condition of the subject for a specific disease is determined. 4. The physiological function measuring method according to claim 1, wherein the mixed state in the intestinal tract of the subject is inspected based on the order or the number of raw soybeans or rice grains discharged from the subject.
【請求項7】被験者に摂取され、被験者の特定の疾患を
計測するための試験用食品であって、 ビタミン、ミネラル類を主体とするベーサル・ダイエッ
トと、食物繊維と、アルブミンと、キシロースと、調香
味成分と水を含み、 予め特定の生理機能を測定するための試料を採取された
被験者に対して、日常の食事摂取量に基づいた量に取り
分けられたことを特徴とする試験用食品。
7. A test food ingested by a subject for measuring a specific disease of the subject, comprising: a basal diet mainly composed of vitamins and minerals; dietary fiber; albumin; xylose; A test food comprising a flavor component and water, the test food being provided in a quantity based on daily dietary intake for a subject from which a sample for measuring a specific physiological function has been collected in advance.
【請求項8】リノレン酸等の脂質をさらに含むようにし
た請求項7に記載の試験用食品。
8. The test food according to claim 7, further comprising a lipid such as linolenic acid.
【請求項9】それぞれ異なる色に着色された複数の生大
豆又は米粒等の粒状食品をさらに混入するようにした請
求項7又は8に記載の試験用食品。
9. The test food according to claim 7, further comprising a plurality of granular foods such as raw soybeans or rice grains colored in different colors.
JP2000082170A 2000-03-23 2000-03-23 Physiological function measurement method and test food Expired - Fee Related JP3611996B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000082170A JP3611996B2 (en) 2000-03-23 2000-03-23 Physiological function measurement method and test food

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000082170A JP3611996B2 (en) 2000-03-23 2000-03-23 Physiological function measurement method and test food

Publications (2)

Publication Number Publication Date
JP2001272392A true JP2001272392A (en) 2001-10-05
JP3611996B2 JP3611996B2 (en) 2005-01-19

Family

ID=18599007

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000082170A Expired - Fee Related JP3611996B2 (en) 2000-03-23 2000-03-23 Physiological function measurement method and test food

Country Status (1)

Country Link
JP (1) JP3611996B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015141201A (en) * 2014-01-29 2015-08-03 立創生医科技股▲ふん▼有限公司 Quantified output system of physiological parameter

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015141201A (en) * 2014-01-29 2015-08-03 立創生医科技股▲ふん▼有限公司 Quantified output system of physiological parameter

Also Published As

Publication number Publication date
JP3611996B2 (en) 2005-01-19

Similar Documents

Publication Publication Date Title
Sauberlich et al. Application of the erythrocyte glutathione reductase assay in evaluating riboflavin nutritional status in a high school student population
Villegas et al. Purine-rich foods, protein intake, and the prevalence of hyperuricemia: the Shanghai Men’s Health Study
Lumbers et al. Nutritional status in elderly female hip fracture patients: comparison with an age-matched home living group attending day centres
Elin Assessment of magnesium status for diagnosis and therapy
Gatenby Eating frequency: methodological and dietary aspects
Peacock et al. Relationship of serum and dietary magnesium to incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study
Free et al. Urinalysis, critical discipline of clinical science
Pelletier Vitamin C Status of Cigarette Smokers an Nonsmokers
Melnick et al. Physiological Availability of the Vitamins: I. The Human Bioassay Technic: One Figure
O'ROURKE et al. Thiamine status of healthy and institutionalized elderly subjects: analysis of dietary intake and biochemical indices
Wierdsma et al. Bomb calorimetry, the gold standard for assessment of intestinal absorption capacity: normative values in healthy ambulant adults
Ship et al. Metabolic indicators of hydration status in the prediction of parotid salivary-gland function
CN115537458A (en) Application of fecal flora detection-based method in evaluation of nutritional metabolism level of vegetarian pregnant women
Free et al. Self testing, an emerging component of clinical chemistry.
Corbin et al. Integrative and quantitative bioenergetics: Design of a study to assess the impact of the gut microbiome on host energy balance
Dimitrov et al. Clinical markers in adult offspring of families with and without Balkan Endemic Nephropathy
Rodríguez-Rodríguez et al. Relationship between 24 h urinary potassium and diet quality in the adult Spanish population
Barewal et al. A comparison of behavior of transitional-state foods under varying oral conditions
Hrnciarikovaª et al. Present state of evaluating malnutrition in the elderly–analysing indicators
JP3611996B2 (en) Physiological function measurement method and test food
Jackson et al. Screening for vitamin C in the urine: is it clinically significant
Kinabo et al. Quality of human capital for agricultural production in rural areas of Morogoro and Iringa regions, Tanzania
Beato et al. Naturally enriched 13 C breath test as a carbohydrate intake marker in obese women
Agbozo et al. Lifestyle habits and perceived wellbeing of adults presenting with metabolic syndrome at a diabetic clinic in Ghana: A case-control study
Jalali Water consumption and factors influencing hydration status

Legal Events

Date Code Title Description
RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20031210

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040727

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040830

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20041019

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20041021

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20071029

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081029

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091029

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091029

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101029

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111029

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111029

Year of fee payment: 7

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111029

Year of fee payment: 7

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121029

Year of fee payment: 8

LAPS Cancellation because of no payment of annual fees